A division of the direct-to-patient telehealth company Ro, Roman provides patients access to a nationwide digital doctor's office and online pharmacy for certain men's health conditions through an integrated platform to enhance the convenience and quality of healthcare delivery.
Greenstone has been a leader in authorized generics for more than 25 years and manufactures sildenafil citrate, a prescription medicine used to treat erectile dysfunction.
The exclusive supply agreement with Roman represents Greenstone's first collaboration with a direct-to-patient telehealth company.
ED affects approximately 30m men in the US, and Viagra is one of the most counterfeited drugs in the world.
The collaboration between Roman and Greenstone, built on Pfizer's quality manufacturing standards, ensures patients have confidence in the quality and consistency of the generic sildenafil citrate they are prescribed and receive as part of their Roman treatment plan.
Under the agreement, Roman's generic sildenafil citrate offering will be sourced exclusively from Greenstone and manufactured in the same European facilities as branded Viagra - at no additional cost to members.
Digital Healthcare, including telemedicine, is a rapidly growing approach to healthcare designed to empower consumers to make better-informed decisions about their own health and provide new options for remote care.
The growth in the digital health industry is due to several demographic and economic factors, including an aging population and a shortage in primary care physicians in the US.
Ro's technology enables physicians to provide high quality care from diagnosis to the delivery of medication all on one platform.
All of the physicians on the Ro platform are licensed in the US and undergo an extensive background check and license verification process.
Ro is a complement, not a replacement, to a patient's overall care. Ro can keep a patient's in-person provider updated on their treatment plan at the patient's request to ensure continuity of care.
ED affects about 30 m men in the US ED is a medical condition often caused by an underlying condition such as heart disease, diabetes or depression.
However, studies show men are 24% less likely than women to go to a doctor over a one-year period and that only 25% of men who experience ED get treated.
The sildenafil citrate authorized generic is equivalent to the Viagra brand.
Greenstone is part of the Upjohn business and a wholly owned subsidiary of Pfizer Inc. (NYSE: PFE), offering a leading portfolio of Authorized Generics.
Greenstone is one of the longest running distributors of Authorized Generics in the US across a broad range of therapeutic areas. Greenstone is committed to quality, value and excellence in everything we do, and dedicated to the goal of helping patients live healthier lives.
Apotex launches Teriparatide Injection in US
Teva Pharmaceuticals secures FDA approval for generic Forteo (teriparatide injection)
Upsher-Smith Laboratories introduces Pitavastatin Tablets
Par Pharmaceutical starts shipping colchicine 0.6mg capsules
Padagis launces Brinzolamide Ophthalmic Suspension with CGT exclusivity
Novartis completes Sandoz Spin-off
Novartis completes Sandoz spin-off, focusing on innovative medicines
Sanofi and Teva collaborate on innovative IBD treatment
Hikma marks KLOXXADO two-year anniversary by surpassing 375,000 doses donated in the US
STADA seeks full approval for Kinpeygo in IgA nephropathy from UK MHRA
Azurity Pharmaceuticals completes Slayback Pharma acquisition
Sandoz secures European approval for Tyruko biosimilar in MS treatment
Senores Pharmaceuticals introduces Nicardipine Hydrochloride Capsules USP, 20mg and 30mg in US
Lupin collaborates with Mark Cuban Cost Plus Drug Company and COPD foundation
Certara Simcyp receives FDA grants for advanced pharmacokinetic modelling